<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

--------------------------------------------------------------------------------

                          China Pharma Holdings, Inc.
--------------------------------------------------------------------------------

August 7, 2008

Mr. John L. Krug
Securities and Exchange Commission
Washington, D.C. 20549


       Re: China Pharma Holdings, Inc.
           Registration Statement on Form S-1
           File No.: 333-152272

Dear Mr. Krug,

Pursuant to Rule 461 under the Securities Act of 1933, as amended,  China Pharma
Holdings,  Inc.,  a  Delaware  corporation  (the  "Company"),   hereby  requests
acceleration of the effective date of its Form S-1/A filed on July 29, 2008, and
hereby  requests that the  effectiveness  of the  above-referenced  registration
statement be accelerated to 12:00 noon, EDST, on Monday,  August 11, 2008, or as
soon as practicable thereafter. We acknowledge the following:

o    Should the Commission or the staff, acting pursuant to delegated authority,
     declare the filing  effective,  it does not foreclose the  Commission  from
     taking any action with respect to the filing;

o    the action of the  Commission  or the staff,  acting  pursuant to delegated
     authority, in declaring the filing effective,  does not relieve the Company
     from  its  full  responsibility  for  the  adequacy  and  accuracy  of  the
     disclosure in the filing; and

o    the  Company  may not assert  this  action as a defense  in any  proceeding
     initiated by the Commission or any person under the federal securities laws
     of the United States.


Yours faithfully,


/s/ Zhilin Li
-------------
Zhilin Li
President and Chief Executive Officer









No.17 Jinpan Rd, Haikou, Hainan, China 570216              Fax:  86-898 66819024
Phone:  86-898 66811911                              www.chinapharmaholdings.com

</TEXT>
</DOCUMENT>
